Stock Of The Day: Where Does The Merck Downtrend End?
Stock Of The Day: Where Does The Merck Downtrend End?
Shares of Merck & Co., Inc. (NYSE:MRK) are trading flat on Thursday, but remain in a downtrend.
默沙東股份公司(紐交所:MRK)的股票在週四交易平穩,但仍處於下行趨勢中。
If the stock eventually reaches levels around $95.00, there is a good chance it reverses and heads higher. As you can see on the chart, this is what happened in late November. This is why our technical analysis team has made it our Stock of the Day.
如果股票最終達到約95.00美元的水平,那麼它反轉並走高的機會將很大。正如您在圖表上看到的,這就是11月底發生的事情。這就是我們的技術面分析團隊將其選爲今日股票的原因。
There has been a lot of news coming from Merck.
默沙東有很多資訊發佈。
The advanced cancer genomic testing provider Personalis, Inc. (NASDAQ:PSNL) said it received a $50 million equity investment from Merck. When the deal closes, Merck will own 16.5% of Personalis.
艾文思控股公司(納斯達克:PSNL)表示,它獲得了來自默沙東的5000萬美元股權投資。交易完成後,默沙東將擁有艾文思控股16.5%的股份。
Merck also announced that it is entering the lucrative obesity market. It is licensing rights from Chinese biotech Hansoh Pharmaceutical Group Company Limited (OTC:HNSPF)to an investigational oral GLP – 1 receptor.
默沙東還宣佈,它正在進入利潤豐厚的肥胖市場。它正在從中國生物科技漢紹藥品集團有限公司(場外交易:HNSPF)獲得一項研究性口服GLP-1受體的許可。
The chart of Merck offers some simple but valuable technical analysis lessons. Price levels that had been resistance can convert into support. Also, stocks that drop to support have a tendency to rally.
默沙東的圖表提供了一些簡單但有價值的技術面分析教訓。曾經的支撐位可以轉換爲壓力位。此外,跌至支撐位的股票往往有反彈的傾向。
Read Also: Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
另請閱讀:泰維藥品發佈了針對腸胃相關疾病的令人印象深刻的第二階段候選數據。
$119.40 was resistance in May 2023. Some of the investors who sold then were happy when the price fell soon after. They thought they made a good decision.
$119.40在2023年5月是支撐位。一些在那時出售的投資者在價格很快下跌時感到高興。他們認爲自己做出了正確的決定。
But in January 2024 the resistance broke and the stock moved higher. When this happened, some of these sellers came to think they made a mistake and decided to buy their shares back if they can do so at the same price they sold them for.
但在2024年1月,支撐位被突破,股票價格上漲。這發生時,一些賣家開始認爲自己犯了錯誤,並決定如果能在他們賣出時的同一價格買回股票。
So, when the stock dropped back to around $119.40 in March 2024 they placed buy orders. The large concentration of these orders formed support at the same price that had been resistance.
因此,當股票在2024年3月回落到約$119.40時,他們下了買入訂單。這些訂單的大量集中在曾經是支撐位的價格形成了壓力位。
Similar action occurred at the $111.00 level. It was resistance in August 2023. Then it became support a year later in August 2024.
在$111.00處也發生了類似的情況。它在2023年8月是支撐位。然後在2024年8月一年後轉變爲支撐位。
In July 2022, the $95.00 level was resistance. It converted into support last month, and it may be support again if Merck reaches it.
在2022年7月,$95.00是支撐位。上個月它轉化爲壓力位,如果默沙東達到這個價格,它可能再次成爲支撐位。
As you can also see on the chart, sometimes stocks rally after they reach support. This happens when some of the buyers who created the support think they will get outbid. If someone else is willing to pay a higher price, that's who the sellers will go to.
正如您在圖表中所看到的,有時股票在達到支撐位後會反彈。這發生在某些創建支撐位的買家認爲他們會被出價更高的買家超越。如果有人願意支付更高的價格,賣家就會去找他們。
As a result, they increase the prices they are willing to pay. Others see this and do the same. It can cause a snowball effect that pushes the stock higher and it may be about to happen with Merck.
因此,他們提高了願意支付的價格。其他人看到這一點也採取了同樣的做法。這可能導致雪球效應,推動股票價格上漲,並且默沙東可能即將發生這種情況。
- Bitcoin Rebounds Above $102,000 Post-Fed Meeting; Us GDP Hits 3.1%, Jobless Claims Drop, Treasury Yields Peak – Top Headlines Today While US Slept
- 比特幣在聯儲局會議後反彈至$102,000以上;美國GDP達到3.1%,失業申請減少,財政收益率達到峯值——今天美國入睡時的頭條新聞
Image: Courtesy of Merck.
圖片:來自默沙東。